摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-氨基-3,5-二甲基苯基)乙酮 | 80539-08-8

中文名称
1-(4-氨基-3,5-二甲基苯基)乙酮
中文别名
——
英文名称
3,5-dimethyl-4-aminoacetophenone
英文别名
4-amino-3,5-dimethylacetophenone;1-(4-Amino-3,5-dimethylphenyl)ethan-1-one;1-(4-amino-3,5-dimethylphenyl)ethanone
1-(4-氨基-3,5-二甲基苯基)乙酮化学式
CAS
80539-08-8
化学式
C10H13NO
mdl
——
分子量
163.219
InChiKey
FKNKEQLUQOXFSP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    326.6±37.0 °C(Predicted)
  • 密度:
    1.047±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    43.1
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] HIV INHIBITING 1,2,4-TRIAZInONE DERIVATIVES<br/>[FR] DÉRIVÉS DE 1,2,4-TRIAZINONE INHIBITEURS DU VIH
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2006015985A1
    公开(公告)日:2006-02-16
    The present invention relates to HIV replication inhibitors of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein ring A and ring B represent phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl; n and m are 1 to 4; R1 represents hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyloxycarbonyl; optionally substituted C1-6alkyl; C1-6alkyloxy C1-6alkylcarbonyl substituted with C1-6alkyloxycarbonyl; their use as a medicine, their use for the manufacture of a medicament for the treatment or the prevention of HIV infection; their processes for preparation and pharmaceutical compositions comprising them.
    本发明涉及公式(I)的HIV复制抑制剂,其中N-氧化物,药学上可接受的加盐物,季铵盐或其立体化学异构体形式,其中环A和环B代表苯基,吡啶基,吡啶并嗪基,嘧啶基或吡嗪基;n和m为1至4;R1代表氢;芳基;甲酰基;C1-6烷基羰基;C1-6烷氧羰基;可选择取代的C1-6烷基;C1-6烷氧基C1-6烷基羰基,其用作药物,用于制造用于治疗或预防HIV感染的药物的药物,其制备方法和包含它们的制药组合物。
  • Hiv Inhibiting 1,2,4-Triazin-6-One Derivatives
    申请人:Hoornaert Georges Joseph Cornelius
    公开号:US20090012092A1
    公开(公告)日:2009-01-08
    The present invention relates to HIV replication inhibitors of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein ring A and ring B represent phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl; n and m are 1 to 4; R 1 represents hydrogen; aryl; formyl; C 1-6 alkylcarbonyl; C 1-6 alkyloxycarbonyl; optionally substituted C 1-6 alkyl; C 1-6 alkyloxyC 1-6 alkylcarbonyl substituted with C 1-6 alkyloxycarbonyl; R 2 or R 4 represents hydrogen; hydroxy; halo; optionally substituted C 1-6 alkyl; optionally substituted C 2-6 alkenyl; optionally substituted C 2-6 alkynyl; C 3-7 cycloalkyl; C 1-6 alkyloxy; C 1-6 alkyloxycarbonyl; C 1-6 alkylcarbonyloxy; carboxyl; cyano; nitro; amino; mono- or di(C 1-6 alkyl)amino; polyhaloC 1-4 alkyl; polyhaloC 1-4 alkyloxy; polyhaloC 1-4 alkylthio; —S(═O) p R 6 ; —NH—S(═O) p R 6 ; —C(═O)R 6 ; —NHC(═O)H; —C(═O)NHNH 2 ; NHC(═O)R 6 ; C(═NH)R 6 ; or R 7 ; R 2a or R 3 represents cyano; aminocarbonyl; amino; halo; NHR 13 ; NR 13 R 14 —C(═O)—NHR 13 ; —C(═O)—NR 13 R 14 ; —C(═O)—R 15 ; —CH═N—NH—C(═O)—R 16 ; optionally substituted C 1-6 alkyl; optionally substituted C 1-6 alkyloxy; optionally substituted C 1-6 alkyloxyC 1-6 alkyl; optionally substituted C 2-6 alkenyl; optionally substituted C 2-6 alkynyl; —C(═N—O—R 8 )—C 1-4 alkyl; R 7 or —X 3 —R 7 ; X 1 or X 2 represents —NR 1 —; —NH—NH—; —N═N—; —O—; —C(═O)—; —C 1-4 alkanediyl-; —CHOH—; —S—; —S(═O) p —; —X 4 —C 1-4 alkanediyl-; —C 1-4 alkanediyl-X 4 —; or —C 1-4 alkanediyl-X 4 —C 1-4 alkanediyl-; their use as a medicine, their use for the manufacture of a medicament for the treatment or the prevention of HIV infection; their processes for preparation and pharmaceutical compositions comprising them.
    本发明涉及公式a的HIV复制抑制剂,其为N-氧化物、药学上可接受的加成盐、季铵盐或其立体化学异构体形式,其中环A和环B代表苯基、吡啶基、吡嗪基、嘧啶基或吡嗪基;n和m为1至4;R1代表氢;芳基;甲酰基;C1-6烷基羰基;C1-6烷氧羰基;可选取代的C1-6烷基;C1-6烷氧基C1-6烷基羰基,其被C1-6烷氧羰基取代;R2或R4代表氢;羟基;卤素;可选取代的C1-6烷基;可选取代的C2-6烯基;可选取代的C2-6炔基;C3-7环烷基;C1-6烷氧基;C1-6烷氧羰基;C1-6烷基羰酰氧基;羧基;氰基;硝基;氨基;单烷基或双烷基(C1-6)氨基;多卤素C1-4烷基;多卤素C1-4烷氧基;多卤素C1-4烷硫基;-S(═O)pR6;-NH-S(═O)pR6;-C(═O)R6;-NHC(═O)H;-C(═O)NHNH2;NHC(═O)R6;C(═NH)R6;或R7;R2a或R3代表氰基;氨基羰基;氨基;卤素;NHR13;NR13R14-C(═O)-NHR13;-C(═O)-NR13R14;-C(═O)-R15;-CH═N-NH-C(═O)-R16;可选取代的C1-6烷基;可选取代的C1-6烷氧基;可选取代的C1-6烷氧基C1-6烷基;可选取代的C2-6烯基;可选取代的C2-6炔基;-C(═N-O-R8)-C1-4烷基;R7或-X3-R7;X1或X2代表-NR1-;-NH-NH-;-N═N-;-O-;-C(═O)-;-C1-4烷二基-;-CHOH-;-S-;-S(═O)p-;-X4-C1-4烷二基-;-C1-4烷二基-X4-;或-C1-4烷二基-X4-C1-4烷二基-;其作为药物的用途,其用于制造用于治疗或预防HIV感染的药物,其制备过程和包含它们的制药组合物。
  • BENZAMIDE DERIVATIVE
    申请人:Chugai Seiyaku Kabushiki Kaisha
    公开号:US20150152047A1
    公开(公告)日:2015-06-04
    The present invention relates to benzamide derivatives represented by formula (I) or pharmaceutically acceptable salts thereof.
    本发明涉及由公式(I)表示的苯甲酰胺衍生物或其药学上可接受的盐。
  • Magdy, M.; Malik, Abdel-; Mayo, Paul de, Canadian Journal of Chemistry, 1984, vol. 62, p. 1275 - 1278
    作者:Magdy, M.、Malik, Abdel-、Mayo, Paul de
    DOI:——
    日期:——
  • [EN] HIV REPLICATION INHIBITING PURINE DERIVATIVES<br/>[FR] DERIVES DE PURINE SERVANT A INHIBER LA REPLICATION DU VIH
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2005028479A3
    公开(公告)日:2005-06-16
查看更多